CHANGES IN HEPATITIS C VIRUS RNA VIREMIA CONCENTRATIONS IN LONG-TERM RENAL TRANSPLANT PATIENTS AFTER INTRODUCTION OF MYCOPHENOLATE MOFETIL

Abstract

Our study suggests that MMF should be used with caution in stable HCV RT patients whose maintenance immunosuppressive therapy is based on cyclosporine, at least in the case of patients with a low HCV RNA titer.